Nanotechnology based platforms for survivin targeted drug discovery

Author： Samarasinghe Rasika M   Gibbons Jessica   Kanwar Rupinder K   Kanwar Jagat R  

Publisher： Informa Healthcare

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.7, Iss.11, 2012-11, pp. : 1083-1092

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Advances in fragment-based drug discovery platforms

By Orita Masaya   Warizaya Masaichi   Amano Yasushi   Ohno Kazuki   Niimi Tatsuya  

Expert Opinion on Drug Discovery, Vol. 4, Iss. 11, 2009-11 ,pp. : 1125-1144

Informa Healthcare

Access to resources Recommend Favorite

Towards microfluidic technology-based MALDI-MS platforms for drug discovery: a review

By Winkle Richard F   Nagy Judit M   Cass Anthony EG   Sharma Sanjiv  

Expert Opinion on Drug Discovery, Vol. 3, Iss. 11, 2008-11 ,pp. : 1281-1292

Informa Healthcare

Access to resources Recommend Favorite

Advances in LC platforms for drug discovery

By Nicoli Raul   Martel Sophie   Rudaz Serge   Wolfender Jean-Luc   Veuthey Jean-Luc   Carrupt Pierre-Alain   Guillarme Davy  

Expert Opinion on Drug Discovery, Vol. 5, Iss. 5, 2010-05 ,pp. : 475-489

Informa Healthcare

Access to resources Recommend Favorite

Ligand–receptor interaction platforms and their applications for drug discovery

By Fang Ye  

Expert Opinion on Drug Discovery, Vol. 7, Iss. 10, 2012-10 ,pp. : 969-988

Informa Healthcare

Access to resources Recommend Favorite

Invertebrate and fungal model organisms: emerging platforms for drug discovery

By Stilwell Geoff E   Westlund Bethany  

Expert Opinion on Drug Discovery, Vol. 3, Iss. 12, 2008-12 ,pp. : 1383-1395

Informa Healthcare

Access to resources Recommend Favorite